SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, ...

WESTBROOK, ME - JANUARY 4: IDEXX Laboratories has been added to the Standard & Poor's 500 Index. (Photo by Ben McCanna/Portland Portland Press Herald via Getty Images) IDEXX Laboratories’ (IDXX) ...

(MENAFN- GetNews) Air Voel, a trusted name in sleep and respiratory wellness across Canada, proudly announces the expansion of its product lineup with the latest ResMed BiPAP and CPAP machines, ...

ResMed posted a 9% revenue increase and an 11% rise in net income for the September quarter, driven by increased demand for sleep treatment products. The company demonstrated strong growth in various ...

ResMed Inc. reported its Q4 2025 earnings, revealing a robust financial performance with revenue reaching $1.35 billion, surpassing the forecast of $1.33 billion. Despite this positive financial ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: ResMed Inc. has initiated ...

Air Voel, one of Canada’s trusted providers of sleep therapy solutions, is proud to announce a major expansion of its offerings across the country, making advanced ResMed CPAP machines more accessible ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

ResMed, an ASX healthcare leader, is well-positioned to capitalise on the growing demand for sleep apnoea treatment and digital health solutions, offering potential long-term rewards. The company's ...

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

When Mick Farrell’s dad, Peter, first invited him to come and work at ResMed, which makes breathing devices for sleep apnoea, he scoffed at the idea. Farrell, an ambitious 26-year-old consultant, was ...

In a pooled analysis of three randomized trials, CPAP had overall null cardiovascular effects in patients with obstructive sleep apnea and cardiovascular disease. However, CPAP leaned toward benefit ...